ArticleScientific reports2022

Transcriptomic changes underlying EGFR inhibitor resistance in human and mouse models of basal-like breast cancer.

Narmeen S Rashid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.